Trials / Conditions / Organ Transplantation

Organ Transplantation

29 registered clinical trials studyying Organ Transplantation — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers NCT06950398	Rennes University Hospital	Phase 2
Not Yet Recruiting	The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Orga NCT07288918	Ondokuz Mayıs University	N/A
Recruiting	Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients NCT06652919	Universität Münster	—
Active Not Recruiting	Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomi NCT05556720	Monash University	Phase 3
Unknown	Immunosuppressants to Postoperative Infection and Death NCT06121804	Chung Shan Medical University	—
Unknown	Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management NCT03997253	University Hospital, Limoges	N/A
Recruiting	Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection) NCT04687865	Hospices Civils de Lyon	—
Unknown	Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen NCT03861962	Assistance Publique - Hôpitaux de Paris	—
Completed	Reducing the Burden of Influenza After Solid-Organ Transplantation NCT03699839	Oriol Manuel	Phase 2 / Phase 3
Completed	Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carb NCT02852902	Spanish Network for Research in Infectious Diseases	—
Completed	Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation NCT05685888	First Affiliated Hospital Xi'an Jiaotong University	—
Completed	Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation NCT01370746	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT) NCT01633424	Stanford University	—
Completed	Remote Ischemic Preconditioning in Neurological Death Organ Donors NCT01515072	Rutgers, The State University of New Jersey	N/A
Unknown	Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Boost NCT01256931	Sahlgrenska University Hospital	—
Completed	Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients NCT01254955	Sahlgrenska University Hospital	—
Unknown	Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patien NCT00987103	Maastricht University Medical Center	Phase 1
Unknown	Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation NCT00792064	Hannover Medical School	—
Completed	Mesenchymal Stem Cells and Subclinical Rejection NCT00734396	Leiden University Medical Center	Phase 1 / Phase 2
Completed	Study of Cancers After Solid Organs Transplants NCT00948883	Assistance Publique - Hôpitaux de Paris	—
Unknown	Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inh NCT00611494	University Health Network, Toronto	Phase 4
Completed	Belatacept Post Depletional Repopulation to Facilitate Tolerance NCT00565773	Allan D Kirk, MD, PhD	Phase 2
Unknown	Immune Monitoring and Assay Development in Organ Transplant Recipients NCT01283295	Emory University	—
Completed	Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease NCT00904579	National Cancer Institute (NCI)	—
Completed	Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen NCT00286871	Duke University	Phase 1
Completed	Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation NCT01123187	University Hospital, Lille	N/A
Recruiting	Leuven Tolerogenic Protocol for Intestinal Transplantation NCT02314949	Universitaire Ziekenhuizen KU Leuven	—
Completed	The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation NCT00213304	The Hospital for Sick Children	Phase 3
No Longer Available	A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Tr NCT00149981	Novartis Pharmaceuticals	—